Degarelix for treating advanced hormone‐sensitive prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Degarelix for Treating Advanced Hormone‐sensitive Prostate Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440200/all/Degarelix_for_treating_advanced_hormone‐sensitive_prostate_cancer_Edited__no_change_to_conclusions_. Accessed 19 April 2024.
Degarelix for treating advanced hormone‐sensitive prostate cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440200/all/Degarelix_for_treating_advanced_hormone‐sensitive_prostate_cancer_Edited__no_change_to_conclusions_. Accessed April 19, 2024.
Degarelix for treating advanced hormone‐sensitive prostate cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/440200/all/Degarelix_for_treating_advanced_hormone‐sensitive_prostate_cancer_Edited__no_change_to_conclusions_
Degarelix for Treating Advanced Hormone‐sensitive Prostate Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440200/all/Degarelix_for_treating_advanced_hormone‐sensitive_prostate_cancer_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Degarelix for treating advanced hormone‐sensitive prostate cancer
ID - 440200
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440200/all/Degarelix_for_treating_advanced_hormone‐sensitive_prostate_cancer_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -